{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:12:24Z","timestamp":1781284344016,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","nutritionjrnl.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.nut.2015.08.016","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T02:46:24Z","timestamp":1443235584000},"page":"236-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["High homocysteine, low vitamin B-6, and increased oxidative stress are independently associated with the risk of chronic kidney disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Cheng-Hsu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ching","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hua","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chien","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2015.08.016_bib1","unstructured":"Statistics of Causes of Death, Health Promotion Administration, Ministry of Health and Welfare,\u00a02014."},{"key":"10.1016\/j.nut.2015.08.016_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/ajkd.2002.29904","article-title":"Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency","volume":"39","author":"Lindner","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nut.2015.08.016_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","article-title":"Association between serum homocysteine and markers of impaired kidney function in adults in the United States","volume":"66","author":"Francis","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nut.2015.08.016_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.nut.2015.08.016_bib5","doi-asserted-by":"crossref","first-page":"c38","DOI":"10.1159\/000245068","article-title":"Vitamin B6 metabolism in chronic kidney disease\u2014relation to transsulfuration, advanced glycation and cardiovascular disease","volume":"114","author":"Busch","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nut.2015.08.016_bib6","first-page":"33","article-title":"Prevalence of hyperhomocysteinemia in chronic kidney disease and effect of supplementation of folic acid and vitamin B12 on cardiovascular mortality","volume":"14","author":"Nand","year":"2013","journal-title":"J Indian Acad Clin Med"},{"key":"10.1016\/j.nut.2015.08.016_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ejim.2014.10.014","article-title":"Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: a historical prospective study","volume":"25","author":"Levi","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.nut.2015.08.016_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1440-1797.2003.00210.x","article-title":"Homocysteine and cardiovascular disease in renal disease","volume":"8","author":"Austen","year":"2003","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.nut.2015.08.016_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.2004080656","article-title":"Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the Atherosclerosis Risk in Communities study","volume":"16","author":"Muntner","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2015.08.016_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.ajkd.2009.01.266","article-title":"Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis","volume":"54","author":"Heinz","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nut.2015.08.016_bib11","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations","volume":"94","author":"Robinson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2015.08.016_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.mnh.0000165896.98372.f4","article-title":"Folic acid supplementation to prevent adverse events in individuals with chronic kidney disease and end stage renal disease","volume":"14","author":"Gonin","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nut.2015.08.016_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1515\/CCLM.2007.266","article-title":"Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study","volume":"45","author":"Palleschi","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.nut.2015.08.016_bib14","first-page":"924","article-title":"Effect of oxidative stress on antioxidant activities, homocysteine and lipoproteins in chronic kidney disease","volume":"21","author":"Atamer","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.nut.2015.08.016_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ndt\/gfp575","article-title":"Oxidative DNA damage in chronic renal failure patients","volume":"25","author":"Stoyanova","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2015.08.016_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.jrn.2011.09.002","article-title":"Intake of antioxidants and their status in chronic kidney disease patients","volume":"22","author":"Sahni","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nut.2015.08.016_bib17","doi-asserted-by":"crossref","first-page":"30192","DOI":"10.1155\/2013\/301982","article-title":"Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease","volume":"2013","author":"Sung","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.nut.2015.08.016_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jn\/131.1.33","article-title":"Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers","volume":"31","author":"Huang","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.nut.2015.08.016_bib19","doi-asserted-by":"crossref","first-page":"12064","DOI":"10.1021\/ja0205481","article-title":"Characterization of endoperoxide and hydroperoxide intermediates in the reaction of pyridoxine with singlet oxygen","volume":"124","author":"Ohta","year":"2002","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nut.2015.08.016_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.freeradbiomed.2003.09.012","article-title":"Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes","volume":"36","author":"Kannan","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nut.2015.08.016_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.thromres.2006.11.008","article-title":"Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus","volume":"120","author":"Signorello","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.nut.2015.08.016_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1024\/0300-9831.79.4.218","article-title":"VitaminB6 compounds are capable of reducing the superoxide radical and lipid peroxide levels induced by H2O2 in vascular endothelial cells in culture","volume":"79","author":"Mahfouz","year":"2009","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.nut.2015.08.016_bib23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.mehy.2011.09.009","article-title":"Hypothesis: Hyperhomocysteinemia is an indicator of oxidant stress","volume":"77","author":"Hoffman","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.nut.2015.08.016_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830260211","article-title":"Making sense of laboratory tests of folate status: Folate requirements to sustain normality","volume":"26","author":"Herbert","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nut.2015.08.016_bib25","series-title":"Dietary reference intakes. Thiamin, riboflavin, niacin, vitamin B-6, folate, vitamin B-12, pantothenic acid, biotin, and choline","year":"1998"},{"key":"10.1016\/j.nut.2015.08.016_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(87)80438-3","article-title":"Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection","volume":"422","author":"Araki","year":"1987","journal-title":"J Chromatogr"},{"key":"10.1016\/j.nut.2015.08.016_bib27","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.nut.2015.08.016_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1570-0232(03)00320-9","article-title":"Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation","volume":"792","author":"Talwar","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.nut.2015.08.016_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0891-5849(01)00584-6","article-title":"Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma","volume":"31","author":"Lapenna","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nut.2015.08.016_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","article-title":"A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation","volume":"37","author":"Erel","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.nut.2015.08.016_bib31","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1681\/ASN.V12102181","article-title":"The kidney and homocysteine metabolism","volume":"12","author":"Friedman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2015.08.016_bib32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/gfm485","article-title":"Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease\u2014results of the renal HOPE-2 study","volume":"23","author":"Mann","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2015.08.016_bib33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","article-title":"Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomised, controlled trial","volume":"47","author":"Zoungas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2015.08.016_bib34","first-page":"S95","article-title":"Vitamin B6 and oxalic acid in clinical nephrology","volume":"20","author":"Mydl\u00edk","year":"2010","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.nut.2015.08.016_bib35","first-page":"619","article-title":"Is vitamin B6 deficiency an under-recognized risk in patients receiving haemodialysis? A systematic review: 2000\u20132010","volume":"16","author":"Corken","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.nut.2015.08.016_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ajcn\/55.1.131","article-title":"The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine","volume":"55","author":"Selhub","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2015.08.016_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI118763","article-title":"The effect of a subnormal vitamin B-6 status on homocysteine metabolism","volume":"98","author":"Ubbink","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nut.2015.08.016_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ajcn\/53.4.935","article-title":"Vitamin B-6 deficiency and renal function and structure in chronically uremic rats","volume":"53","author":"Wolfson","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2015.08.016_bib39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1159\/000169060","article-title":"Oral pyridoxine in the prevention of oxalate kidney stones","volume":"16","author":"Goldenberg","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nut.2015.08.016_bib40","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1681\/ASN.V104840","article-title":"Intake of vitamins B6 and C and the risk of kidney stones in women","volume":"10","author":"Curhan","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2015.08.016_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/jren.2003.50021","article-title":"Inflammation in ESRD: Causes and potential consequences","volume":"13","author":"Kaysen","year":"2003","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nut.2015.08.016_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1099-1271(1998090)13:5<315::AID-BIO491>3.0.CO;2-6","article-title":"Total antioxidant capacity (TAC): Is it an effective method to evaluatethe oxidative stress in uraemia?","volume":"13","author":"Bergesio","year":"1998","journal-title":"J Biolumin Chemilumin"},{"key":"10.1016\/j.nut.2015.08.016_bib43","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nut.2015.08.016_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000112413","article-title":"Increase in oxidative stress but not in antioxidant capacity with advanced stages of chronic kidney disease","volume":"28","author":"Karamouzis","year":"2008","journal-title":"Am J Nephrol"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900715003780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900715003780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T09:12:05Z","timestamp":1653210725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900715003780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0899900715003780"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2015.08.016","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High homocysteine, low vitamin B-6, and increased oxidative stress are independently associated with the risk of chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2015.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}